Education
About Us
Working with TipRanks
Follow Us
Genix Pharmaceuticals (TSE:GENX)
:GENX
GENX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.09
Previous CloseN/A
VolumeN/A
Average Volume (3M)9.14K
Market Cap
C$2.07M
Enterprise ValueC$2.48M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.02
Next Earnings
Sep 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding59,224,133
10 Day Avg. Volume5,700
30 Day Avg. Volume9,143
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Genix Pharmaceuticals News
GENX FAQ
What was Genix Pharmaceuticals’s price range in the past 12 months?
Genix Pharmaceuticals lowest stock price was C$0.02 and its highest was C$0.09 in the past 12 months.
What is Genix Pharmaceuticals’s market cap?
Genix Pharmaceuticals’s market cap is C$2.07M.
When is Genix Pharmaceuticals’s upcoming earnings report date?
Genix Pharmaceuticals’s upcoming earnings report date is Sep 25, 2025 which is in 44 days.
How were Genix Pharmaceuticals’s earnings last quarter?
Genix Pharmaceuticals released its earnings results on Jun 18, 2025. The company reported -C$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.001.
Is Genix Pharmaceuticals overvalued?
According to Wall Street analysts Genix Pharmaceuticals’s price is currently Overvalued.
Does Genix Pharmaceuticals pay dividends?
Genix Pharmaceuticals does not currently pay dividends.
What is Genix Pharmaceuticals’s EPS estimate?
Genix Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genix Pharmaceuticals have?
Genix Pharmaceuticals has 59,224,133 shares outstanding.
What happened to Genix Pharmaceuticals’s price movement after its last earnings report?
Genix Pharmaceuticals reported an EPS of -C$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Genix Pharmaceuticals?
Currently, no hedge funds are holding shares in TSE:GENX
Company Description
Genix Pharmaceuticals
Genix Pharmaceuticals Corp is a Canadian life sciences company engaged in the research, development, manufacturing and marketing of high growth, high margin, novel and proprietary, evidence-based, pharmaceuticals, over-the-counter products, nutraceuticals and healthcare products, as well as generic medicines.
Technical Analysis
Alchemist Mining
―
NeutriSci International
―
Lifeist Wellness
―
Hash Corporation
―
Hempshire Group Inc
―
Ownership Overview
1.50% Insiders
―
Mutual Funds
― Other Institutional Investors
98.50% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---